⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL871716 | 1.00 | — | — | |
| SCHEMBL9081638 | 1.00 | — | — | |
| SCHEMBL3490626 | 0.97 | CYP2C19 (0.41) | — | |
| SCHEMBL2670495 | 0.97 | CYP2C19 (0.41) | — | |
| SCHEMBL1543632 | 0.97 | CYP2C19 (0.41) | — | |
| SCHEMBL3490629 | 0.97 | CYP2C19 (0.41) | — | |
| SCHEMBL1543362 | 0.97 | CYP2C19 (0.41) | — | |
| SCHEMBL19295530 | 0.97 | CYP2C19 (0.41) | — | |
| SCHEMBL31049605 | 0.87 | CYP2C19 (0.35) | — | |
| SCHEMBL13913146 | 0.84 | ATM (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115074734-B | Copper-reducing additive for aluminum substrate circuit board and preparation method and use method thereof | 深圳市板明科技股份有限公司 | 2022-11-08 | — | — | CN | claimed |
| CN-115074734-A | Copper-reducing additive for aluminum substrate circuit board and preparation method and use method thereof | 深圳市板明科技股份有限公司 | 2022-09-20 | — | — | CN | claimed |
| CN-107903161-A | A kind of synthetic method of cis 3 hydroxycyclobutyl formic acid | 上海毕路得医药科技有限公司 | 2018-04-13 | — | — | CN | claimed |
| US-20260138991-A1 | SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES | MOMA THERAPEUTICS INC (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4737443-A1 | SALT-INDUCIBLE KINASE INHIBITORY COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | Tanabe Pharma Corporation (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-20260092069-A1 | SUBSTITUTED INDAZOLES AS IRAK4 INHIBITORS | ASTRAZENECA AB (SE) | 2026-04-02 | — | — | US | disclosed |
| EP-4705298-A2 | SEMI-SATURATED BICYCLIC DERIVATIVES AND RELATED USES | Moma Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20260062387-A1 | SALT-INDUCIBLE KINASE INHIBITOR COMPOUND AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2026-03-05 | — | — | US | disclosed |
| US-12559508-B2 | Semi-saturated bicyclic derivatives and related uses | MOMA THERAPEUTICS, INC. (US) | 2026-02-24 | — | — | US | disclosed |
| US-20260028350-A1 | TOXIN MOLECULE SUITABLE FOR ANTIBODY-DRUG CONJUGATE | MINGHUI PHARMACEUTICAL HANGZHOU LTD (CN) | 2026-01-29 | — | — | US | disclosed |
| US-20260022116-A1 | IMIDAZOPYRIDINE COMPOUNDS, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF | SANOFI-AVENTIS RECHERCHE & DÉVELOPPEMENT (FR) | 2026-01-22 | — | — | US | disclosed |
| WO-2017001354-A1 | POLYCYCLIC AMIDE DERIVATIVES AS CDK9 INHIBITORS | ASTRAZENECA AB (SE) | 2017-01-05 | — | — | WO | disclosed |
| US-20160376287-A1 | Chemical Compounds | ASTRAZENECA AB (SE) | 2016-12-29 | — | — | US | disclosed |
| US-20120232277-A1 | PROCESS FOR THE PREPARATION OF 1,2,4-OXADIAZOL-3-YL DERIVATIVES OF CARBOXYLIC ACID | ABBOTT LABORATORIES (US) | 2012-09-13 | — | — | US | disclosed |
| WO-2012122338-A1 | PROCESS FOR THE PREPARATION OF 1,2,4-OXADIAZOL-3-YL DERIVATIVES OF CARBOXYLIC ACID | ABBOTT LABORATORIES (US) | 2012-09-13 | — | — | WO | disclosed |
| US-20120232277-A1 | PROCESS FOR THE PREPARATION OF 1,2,4-OXADIAZOL-3-YL DERIVATIVES OF CARBOXYLIC ACID | ABBOTT LABORATORIES (US) | 2012-09-13 | — | — | US | disclosed |
| US-8247441-B2 | Chromene compounds, a process for their preparation and pharmaceutical compositions containing them | LES LABORATOIRES SERVIER (FR) | 2012-08-21 | — | — | US | disclosed |
| WO-2011071570-A1 | NOVEL OXADIAZOLE COMPOUNDS | ABBOTT LABORATORIES (US) | 2011-06-16 | — | — | WO | disclosed |
| US-20110021490-A1 | Chromene compounds, a process for their preparationand pharmaceutical compositions containing them | LES LABORATOIRES SERVIER (FR) | 2011-01-27 | — | — | US | disclosed |
| CN-101321738-A | Spirocyclic derivatives | PFIZER LTD (GB) | 2008-12-10 | — | — | CN | disclosed |